Basit öğe kaydını göster

A Phase II, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major.

dc.contributor.authorYesılıpek, M akif
dc.contributor.authorKarasu, Gulsun
dc.contributor.authorKaya, Zuhre
dc.contributor.authorKuskonmaz, B Baris
dc.contributor.authorUygun, Vedat
dc.contributor.authorDag, I
dc.contributor.authorOzudugru, O
dc.contributor.authorErtem, Mehmet
dc.date.accessioned2020-10-21T12:57:02Z
dc.date.available2020-10-21T12:57:02Z
dc.date.issued2018
dc.identifier.urihttp://hdl.handle.net/11655/23042
dc.language.isoentr_TR
dc.rightsinfo:eu-repo/semantics/openAccesstr_TR
dc.subjectDeferasiroxtr_TR
dc.subjecttranspantationtr_TR
dc.titleA Phase II, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major.tr_TR
dc.typeinfo:eu-repo/semantics/articletr_TR
dc.contributor.departmentÇocuk Sağlığı ve Hastalıklarıtr_TR
dc.description.indexWoStr_TR
dc.fundingYoktr_TR


Bu öğenin dosyaları:

Ad:
68-APH~1.PDF
Boyut:
398.1Kb
Biçim:
PDF
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster